skip to content

Contract Wins and Joint Ventures

BATM's Adaltis in China strategic JV

30 June 2016 07:53

BATM Advanced Communications' wholly-owned subsidiary Adaltis, a manufacturer of medical diagnostics equipment, has entered into an investment agreement and a strategic joint venture with its Chinese partner, Egens Biotechnology Co.

Egens will purchase RMB20m (approximately US$3m) of new shares in Adaltis, equivalent to approximately 5.5% of Adaltis's enlarged share capital, valuing Adaltis at approximately US$58m.

Egens has been granted an option to purchase a further 10%, which will be exercisable for 90 days after the approval of either Adaltis's 2016 or 2017 financial statements. The purchase price is expected to be based on a valuation of Adaltis at 5.5 times turnover.

Egens has deposited a non-refundable €200,000 with BATM to guarantee the execution of the deal within 90 days.

On the establishment of Adaltis Bio Med Company, a joint venture between Adaltis and Egens, in February 2014, Adaltis received a 40% interest in ABC with the balance of 60% interest held by Egens in consideration of its US$1m investment into ABC.

As part of this transaction, Egens is to make a further investment, by way of a shareholder loan, to ABC of US$1.5m. Following this investment, Adaltis' interest in ABC will remain at 40%.

ABC was established to provide Chinese customers with a multi-item imported diagnostic reagent product service for instruments and reagents.

BATM says ABC has signed its first major distribution agreement with Sino Pharm - a prominent Chinese medical and healthcare group - to distribute Adaltis HCV (Hepatitis C) nationwide. China is the world's largest market for Hepatitis.

BATM's diagnostics business is focused on developing compact, high accuracy, cost-effective products for small- to mid-size laboratories, including advanced genomic solutions that are being introduced to the market. In particular, the Group is targeting markets where many laboratories are mid-sized and dispersed in different localities - and hence require the solutions provided by the Group's diagnostics business.

Story provided by StockMarketWire.com

Related Company: BVC

Info Point:

To buy or sell shares call our Dealing Room on 0113 243 6941.

Too much jargon? Our glossary will help make sense of things.

Find out more about our Share Dealing Services.

Client Area Access

» Secure Login

» Not registered yet?

-

Branch Finder

Redmayne-Bentley have High Street branches throughout the UK. Find your nearest branch.